The FDA’s medical device reporting program recently announced that as of February 1, it had received 359 reports of anaplastic large cell lymphoma (ALCL), a rare type of non-Hodgkin’s lymphoma, in women who had received breast implants. Nine women had died of the disease. The FDA uses such reports to alert clinicians about potential significant…

Some women with breast implants may be at risk for developing a rare type of lymphoma, according to a recent statement released by the Food and Drug Administration (FDA). In 2011, the FDA stated that there may be a correlation between breast implants and anaplastic large cell lymphoma. It has been researched and studied since,…